Clinical trial
Evaluation of the Efficacy and Safety of the Transcatheter Aortic Valve Replacement System in Patients With Severe Aortic Valve Stenosis Disease at High Surgical Risk
NCT04836897 is registered in ClinicalTrials.gov with Shanghai NewMed Medical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of the Transcatheter Aortic Valve Replacement System in Patients With Severe Aortic Valve Stenosis Disease at High Surgical Risk
- Lead sponsor
- Shanghai NewMed Medical Co., Ltd.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 19, 2021
- Completion date
- June 30, 2028
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.